{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:02:49Z","timestamp":1789506169335,"version":"build-2803163510"},"reference-count":274,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA291991"],"award-info":[{"award-number":["R01CA291991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbcan.2026.189560","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:23:24Z","timestamp":1771287804000},"page":"189560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular insights for the tumor suppressor role of SPOP in prostate cancer"],"prefix":"10.1016","volume":"1881","author":[{"given":"Peiqiang","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xutong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nrm3982","article-title":"The unravelling of the ubiquitin system","volume":"16","author":"Ciechanover","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrc1881","article-title":"Ubiquitin ligases: cell-cycle control and cancer","volume":"6","author":"Nakayama","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrm2673","article-title":"Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways","volume":"10","author":"Schulman","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(83)90131-9","article-title":"Ubiquitin: roles in protein modification and breakdown","volume":"34","author":"Hershko","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189560_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbcan.2026.189560_bb0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.genet.30.1.405","article-title":"Ubiquitin-dependent protein degradation","volume":"30","author":"Hochstrasser","year":"1996","journal-title":"Annu. Rev. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0035","first-page":"50","article-title":"Targeting the ubiquitin pathway for cancer treatment","volume":"1855","author":"Liu","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrm.2016.91","article-title":"Structural insights into the catalysis and regulation of E3 ubiquitin ligases","volume":"17","author":"Buetow","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nsmb.2780","article-title":"New insights into ubiquitin E3 ligase mechanism","volume":"21","author":"Berndsen","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189560_bb0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","article-title":"RING domain E3 ubiquitin ligases","volume":"78","author":"Deshaies","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189560_bb0055","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/emboj.2013.173","article-title":"The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications","volume":"32","author":"Genschik","year":"2013","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41585-020-0314-z","article-title":"The diverse roles of SPOP in prostate cancer and kidney cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.molcel.2009.09.022","article-title":"Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases","volume":"36","author":"Zhuang","year":"2009","journal-title":"Mol. Cell"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189560_bb0070","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.7150\/thno.113356","article-title":"Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer","volume":"15","author":"Yang","year":"2025","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/0008-5472.CAN-22-2801","article-title":"Deregulation of SPOP in cancer","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0080","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat. Genet."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189560_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-5793(97)01340-9","article-title":"Identification of a novel nuclear speckle-type protein, SPOP","volume":"418","author":"Nagai","year":"1997","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12943-019-1124-x","article-title":"The emerging role of SPOP protein in tumorigenesis and cancer therapy","volume":"19","author":"Song","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molcel.2018.08.027","article-title":"Cancer mutations of the tumor suppressor SPOP disrupt the formation of active, phase-separated compartments","volume":"72","author":"Bouchard","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189560_bb0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.sbi.2016.08.001","article-title":"Liquid-liquid phase separation in cellular signaling systems","volume":"41","author":"Chong","year":"2016","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41419-024-06565-1","article-title":"SPOP point mutations regulate substrate preference and affect its function","volume":"15","author":"Deng","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189560_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112882","article-title":"Novel insights into the SPOP E3 ubiquitin ligase: from the regulation of molecular mechanisms to tumorigenesis","volume":"149","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0115","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41416-020-01197-6","article-title":"Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer","volume":"124","author":"Nikhil","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113247","article-title":"Molecular interplay between AURKA and SPOP dictates CRPC pathogenesis via androgen receptor","volume":"12","author":"Nikhil","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7686","key":"10.1016\/j.bbcan.2026.189560_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189560_bb0130","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/1078-0432.CCR-21-1010","article-title":"ATR inhibition induces CDK1-SPOP signaling and enhances anti-PD-L1 cytotoxicity in prostate Cancer","volume":"27","author":"Tang","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbrc.2020.05.187","article-title":"Snail promotes prostate cancer migration by facilitating SPOP ubiquitination and degradation","volume":"529","author":"Lv","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2005.03.012","article-title":"SUMO: a history of modification","volume":"18","author":"Hay","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189560_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2017.09.001","article-title":"SUMO proteins: guardians of immune system","volume":"84","author":"Adorisio","year":"2017","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nsmb.3366","article-title":"Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation","volume":"24","author":"Hendriks","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0155","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.15252\/embj.201593169","article-title":"Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles","volume":"35","author":"Marzahn","year":"2016","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrg1834","article-title":"Inherited epigenetic variation--revisiting soft inheritance","volume":"7","author":"Richards","year":"2006","journal-title":"Nat. Rev. Genet."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.435","article-title":"Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer","volume":"7","author":"Zhi","year":"2016","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12038-014-9432-1","article-title":"Differential expression of speckled POZ protein, SPOP: putative regulation by miR-145","volume":"39","author":"Huang","year":"2014","journal-title":"J. Biosci."},{"key":"10.1016\/j.bbcan.2026.189560_bb0175","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.2147\/OTT.S161316","article-title":"miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer","volume":"11","author":"Xu","year":"2018","journal-title":"Onco. Targets Ther."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189560_bb0180","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1158\/0008-5472.CAN-18-1662","article-title":"The E2F1-miR-520\/372\/373-SPOP Axis modulates progression of renal carcinoma","volume":"78","author":"Ding","year":"2018","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","volume":"21","author":"Lee","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ccr.2014.02.007","article-title":"SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer","volume":"25","author":"Li","year":"2014","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189560_bb0195","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.ejca.2014.08.009","article-title":"Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer","volume":"50","author":"Garcia-Flores","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189560_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101011","article-title":"Corrigendum to \u201cSPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway\u201d [neoplasia (2021) 23, 1037-1047]","volume":"55","author":"Luo","year":"2024","journal-title":"Neoplasia"},{"issue":"33","key":"10.1016\/j.bbcan.2026.189560_bb0205","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/onc.2017.80","article-title":"SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein","volume":"36","author":"Geng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189560_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.01.003","article-title":"Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells","volume":"390","author":"Zhang","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0215","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/1541-7786.MCR-21-0108","article-title":"GLI3 is stabilized by SPOP mutations and promotes castration resistance via functional cooperation with androgen receptor in prostate cancer","volume":"20","author":"Burleson","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189560_bb0220","article-title":"The SPOP-ITCH signaling Axis protects against prostate cancer metastasis","volume":"11","author":"Ma","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189560_bb0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2016.10.021","article-title":"Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation","volume":"385","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb0230","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm.4379","article-title":"Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation","volume":"23","author":"Zhang","year":"2017","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb0235","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nm.4372","article-title":"Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors","volume":"23","author":"Janouskova","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-019-1096-x","article-title":"Prostate cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly","volume":"18","author":"Shi","year":"2019","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0245","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41419-024-06647-0","article-title":"ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance","volume":"15","author":"Lee","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb0250","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nm.4378","article-title":"Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4","volume":"23","author":"Dai","year":"2017","journal-title":"Nat. Med."},{"issue":"25","key":"10.1016\/j.bbcan.2026.189560_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd9208","article-title":"ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication","volume":"7","author":"Wang","year":"2021","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0260","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1093\/nar\/gkab489","article-title":"Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP-HIPK2 axis","volume":"49","author":"Jin","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41392-020-00381-7","article-title":"A disease-relevant mutation of SPOP highlights functional significance of ATM-mediated DNA damage response","volume":"6","author":"Xiao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189560_bb0270","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1073\/pnas.0408918102","article-title":"Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3\/SPOP ubiquitin E3 ligase","volume":"102","author":"Hernandez-Munoz","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb0275","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1172\/JCI40440","article-title":"Pcif1 modulates Pdx1 protein stability and pancreatic beta cell function and survival in mice","volume":"120","author":"Claiborn","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb0280","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/pros.23793","article-title":"Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase","volume":"79","author":"Gang","year":"2019","journal-title":"Prostate"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189560_bb0285","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/0008-5472.CAN-20-3258","article-title":"Mutated SPOP E3 ligase promotes 17betaHSD4 protein degradation to drive Androgenesis and prostate Cancer progression","volume":"81","author":"Shi","year":"2021","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0290","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.celrep.2015.09.083","article-title":"SPOP E3 ubiquitin ligase adaptor promotes cellular senescence by degrading the SENP7 deSUMOylase","volume":"13","author":"Zhu","year":"2015","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113857","article-title":"LRP5 competes for SPOP binding to enhance tumorigenesis mediated by Daxx and PD-L1 in prostate cancer","volume":"434","author":"Gan","year":"2024","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ccell.2025.12.013","article-title":"Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage","volume":"44","author":"Li","year":"2026","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0305","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013498","article-title":"CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy","volume":"14","author":"Yan","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0310","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2018.11.035","article-title":"SPOP promotes Nanog destruction to suppress stem cell traits and prostate cancer progression","volume":"48","author":"Zhang","year":"2019","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2018.11.033","article-title":"AMPK promotes SPOP-Mediated NANOG degradation to regulate prostate cancer cell stemness","volume":"48","author":"Wang","year":"2019","journal-title":"Dev. Cell"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb0320","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/humu.22614","article-title":"Destruction of DDIT3\/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants","volume":"35","author":"Zhang","year":"2014","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0325","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12943-021-01397-5","article-title":"SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions","volume":"20","author":"Jiang","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0330","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/s41467-021-25951-3","article-title":"SPOP mutation induces DNA methylation via stabilizing GLP\/G9a","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0335","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s41418-021-00913-w","article-title":"SPOP mutations promote p62\/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer","volume":"29","author":"Shi","year":"2022","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb0340","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/apm.12030","article-title":"Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers","volume":"121","author":"Kim","year":"2013","journal-title":"APMIS"},{"issue":"7333","key":"10.1016\/j.bbcan.2026.189560_bb0345","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09744","article-title":"The genomic complexity of primary human prostate cancer","volume":"470","author":"Berger","year":"2011","journal-title":"Nature"},{"issue":"S1","key":"10.1016\/j.bbcan.2026.189560_bb0350","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2017.166","article-title":"The genomics of prostate cancer: emerging understanding with technologic advances","volume":"31","author":"Rubin","year":"2018","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0355","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/pros.23383","article-title":"Ductal adenocarcinoma of the prostate: clinical and biological profiles","volume":"77","author":"Vinceneux","year":"2017","journal-title":"Prostate"},{"issue":"18","key":"10.1016\/j.bbcan.2026.189560_bb0360","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1093\/nar\/gky719","article-title":"SPOP promotes transcriptional expression of DNA repair and replication factors to prevent replication stress and genomic instability","volume":"46","author":"Hjorth-Jensen","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189560_bb0365","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09207","article-title":"SPOP mutation leads to genomic instability in prostate cancer","volume":"4","author":"Boysen","year":"2015","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb0370","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/carcin\/bgu022","article-title":"Speckle-type POZ protein, SPOP, is involved in the DNA damage response","volume":"35","author":"Zhang","year":"2014","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0375","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ccell.2017.02.004","article-title":"SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K\/mTOR and AR signaling","volume":"31","author":"Blattner","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020303","article-title":"Follow the mutations: toward class-specific, small-molecule reactivation of p53","volume":"10","author":"Loh","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/pros.23934","article-title":"Prostate cancer research: the next generation; report from the 2019 Coffey-Holden prostate Cancer academy meeting","volume":"80","author":"Miyahira","year":"2020","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0390","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cell.2015.06.053","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"162","author":"Robinson","year":"2015","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.bbcan.2026.189560_bb0395","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1158\/0008-5472.CAN-14-0476","article-title":"Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer","volume":"74","author":"Geng","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0400","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ccell.2016.04.012","article-title":"TRIM24 is an oncogenic transcriptional activator in prostate Cancer","volume":"29","author":"Groner","year":"2016","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189560_bb0405","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1073\/pnas.1304502110","article-title":"Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover","volume":"110","author":"Geng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109665","article-title":"Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer","volume":"36","author":"Tewari","year":"2021","journal-title":"Cell Rep."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189560_bb0415","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-18-0937","article-title":"SPOP-mutated\/CHD1-deleted lethal prostate Cancer and Abiraterone sensitivity","volume":"24","author":"Boysen","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109625","article-title":"Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity","volume":"36","author":"Grbesa","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189560_bb0425","article-title":"Prospective genomic profiling of prostate Cancer across disease states reveals germline and somatic alterations that may affect clinical decision making","volume":"2017","author":"Abida","year":"2017","journal-title":"JCO Precis. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0430","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc2681","article-title":"Emerging roles of ATF2 and the dynamic AP1 network in cancer","volume":"10","author":"Lopez-Bergami","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb0435","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/j.1460-2075.1989.tb03610.x","article-title":"Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain","volume":"8","author":"Maekawa","year":"1989","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0440","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/bies.20734","article-title":"The role of ATF-2 in oncogenesis","volume":"30","author":"Vlahopoulos","year":"2008","journal-title":"Bioessays"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0445","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/path.1910","article-title":"The p38 transduction pathway in prostatic neoplasia","volume":"208","author":"Ricote","year":"2006","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0450","first-page":"366","article-title":"Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer","volume":"9","author":"Zhang","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0455","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-018-0809-0","article-title":"SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression","volume":"37","author":"Ma","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb0460","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014217","article-title":"MYC, metabolism, cell growth, and tumorigenesis","volume":"3","author":"Dang","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0465","first-page":"1535","article-title":"Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia","volume":"46","author":"Fleming","year":"1986","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb0470","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.2008.111","article-title":"Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis","volume":"21","author":"Gurel","year":"2008","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0475","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/pcan.2010.31","article-title":"Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence","volume":"13","author":"Hawksworth","year":"2010","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0480","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7150\/ijbs.8756","article-title":"Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation","volume":"10","author":"Vander Griend","year":"2014","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb0485","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/pros.22828","article-title":"Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR\/beta-catenin\/TCF-4 complex inhibition of c-MYC transcription","volume":"74","author":"Antony","year":"2014","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb0490","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1172\/JCI200319035","article-title":"Myc confers androgen-independent prostate cancer cell growth","volume":"112","author":"Bernard","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189560_bb0495","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1002\/cncr.26729","article-title":"Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy","volume":"118","author":"Zafarana","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0500","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4161\/cc.11.1.18775","article-title":"An integrated view of cyclin E function and regulation","volume":"11","author":"Siu","year":"2012","journal-title":"Cell Cycle"},{"issue":"5540","key":"10.1016\/j.bbcan.2026.189560_bb0505","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.1065203","article-title":"Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase","volume":"294","author":"Koepp","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0510","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation","volume":"8","author":"Welcker","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.04.036","article-title":"The Fbxw7\/hCdc4 tumor suppressor in human cancer","volume":"271","author":"Tan","year":"2008","journal-title":"Cancer Lett."},{"issue":"6750","key":"10.1016\/j.bbcan.2026.189560_bb0520","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/45836","article-title":"Deregulated cyclin E induces chromosome instability","volume":"401","author":"Spruck","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0525","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2005.06.010","article-title":"A mouse model for cyclin E-dependent genetic instability and tumorigenesis","volume":"8","author":"Loeb","year":"2005","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189560_bb0530","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/sj.onc.1208613","article-title":"Cyclin E in normal and neoplastic cell cycles","volume":"24","author":"Hwang","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0535","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/MCB.17.1.453","article-title":"Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E","volume":"17","author":"Bortner","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189560_bb0540","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa021153","article-title":"Cyclin E and survival in patients with breast cancer","volume":"347","author":"Keyomarsi","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0545","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41418-018-0198-0","article-title":"SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability","volume":"26","author":"Ju","year":"2019","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0550","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11418-025-01885-8","article-title":"Berberine diminishes the malignant progression of non-small cell lung cancer cells by targeting CDCA5 and CCNA2","volume":"79","author":"Zhao","year":"2025","journal-title":"J. Nat. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0555","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8602","article-title":"[corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway","volume":"50","author":"Ji","year":"2023","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0560","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2174\/1568009617666170522094730","article-title":"The complexity of DEK signaling in cancer progression","volume":"18","author":"Teng","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0565","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.18632\/oncotarget.2809","article-title":"Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"issue":"6205","key":"10.1016\/j.bbcan.2026.189560_bb0570","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1250255","article-title":"Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer","volume":"346","author":"Theurillat","year":"2014","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0575","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccr.2009.09.029","article-title":"Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase","volume":"16","author":"Zhang","year":"2009","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189560_bb0580","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1101\/gad.242131.114","article-title":"Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase","volume":"28","author":"Zheng","year":"2014","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0585","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/0008-5472.CAN-09-1876","article-title":"Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors","volume":"70","author":"Henze","year":"2010","journal-title":"Cancer Res."},{"issue":"5748","key":"10.1016\/j.bbcan.2026.189560_bb0590","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189560_bb0595","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1158\/0008-5472.CAN-17-0686","article-title":"Loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion","volume":"77","author":"Yang","year":"2017","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189560_bb0600","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.ejca.2005.08.013","article-title":"ETS transcription factors and their emerging roles in human cancer","volume":"41","author":"Seth","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0605","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI96551","article-title":"SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG","volume":"128","author":"Shoag","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0610","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2015.07.025","article-title":"Truncated ERG Oncoproteins from TMPRSS2-ERG fusions are resistant to SPOP-mediated proteasome degradation","volume":"59","author":"An","year":"2015","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0615","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molcel.2015.07.026","article-title":"SPOP promotes ubiquitination and degradation of the ERG oncoprotein to suppress prostate cancer progression","volume":"59","author":"Gan","year":"2015","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb0620","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc2695","article-title":"Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family","volume":"9","author":"Xu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0625","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1074\/jbc.M109.085779","article-title":"Identification of SRC3\/AIB1 as a preferred coactivator for hormone-activated androgen receptor","volume":"285","author":"Zhou","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb0630","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/pros.21130","article-title":"Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells","volume":"70","author":"Heemers","year":"2010","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb0635","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/me.2015-1080","article-title":"miR-137 targets p160 steroid receptor coactivators SRC1, SRC2, and SRC3 and inhibits cell proliferation","volume":"29","author":"Eedunuri","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189560_bb0640","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biocel.2017.12.005","article-title":"Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3\/IGF1R\/AKT pathway","volume":"94","author":"Xiong","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"42","key":"10.1016\/j.bbcan.2026.189560_bb0645","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1038\/onc.2011.151","article-title":"Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3\/AIB1","volume":"30","author":"Li","year":"2011","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb0650","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0655","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmed.2005.03.004","article-title":"Interference with HH-GLI signaling inhibits prostate cancer","volume":"11","author":"Stecca","year":"2005","journal-title":"Trends Mol. Med."},{"issue":"34","key":"10.1016\/j.bbcan.2026.189560_bb0660","doi-asserted-by":"crossref","first-page":"12561","DOI":"10.1073\/pnas.0404956101","article-title":"Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling","volume":"101","author":"Sanchez","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0665","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ydbio.2017.04.002","article-title":"Spop regulates Gli3 activity and Shh signaling in dorsoventral patterning of the mouse spinal cord","volume":"432","author":"Cai","year":"2017","journal-title":"Dev. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0670","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2008.07.164","article-title":"Itch regulates p45\/NF-E2 in vivo by Lys63-linked ubiquitination","volume":"375","author":"Lee","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb0675","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1007\/s13277-014-2006-x","article-title":"Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?","volume":"35","author":"Byrne","year":"2014","journal-title":"Tumour Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0680","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1158\/0008-5472.CAN-03-3331","article-title":"PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer","volume":"64","author":"Wang","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0685","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mc.20481","article-title":"PrLZ expression is associated with the progression of prostate cancer LNCaP cells","volume":"48","author":"Li","year":"2009","journal-title":"Mol. Carcinog."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0690","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/0008-5472.CAN-10-1791","article-title":"PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3\/Bcl-2 pathway","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0695","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/carcin\/bgs337","article-title":"Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage","volume":"34","author":"Li","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0700","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7150\/thno.20356","article-title":"PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1\/AMPK-mediated autophagy","volume":"8","author":"Zeng","year":"2018","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb0705","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41418-022-00951-y","article-title":"ERK1\/2 inhibits Cullin 3\/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression","volume":"29","author":"Fan","year":"2022","journal-title":"Cell Death Differ."},{"issue":"7327","key":"10.1016\/j.bbcan.2026.189560_bb0710","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb0715","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrc3256","article-title":"BET domain co-regulators in obesity, inflammation and cancer","volume":"12","author":"Belkina","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0720","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0725","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2014.05.016","article-title":"The mechanisms behind the therapeutic activity of BET bromodomain inhibition","volume":"54","author":"Shi","year":"2014","journal-title":"Mol. Cell"},{"issue":"7504","key":"10.1016\/j.bbcan.2026.189560_bb0730","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature13229","article-title":"Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer","volume":"510","author":"Asangani","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0735","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.celrep.2017.12.078","article-title":"BRD4 promotes DNA repair and mediates the formation of TMPRSS2-ERG gene rearrangements in prostate Cancer","volume":"22","author":"Li","year":"2018","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189560_bb0740","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1080\/15384101.2017.1388973","article-title":"SPOP-mediated degradation of BRD4 dictates cellular sensitivity to BET inhibitors","volume":"16","author":"Dai","year":"2017","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0745","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.molcel.2018.06.036","article-title":"DUB3 promotes BET inhibitor resistance and cancer progression by deubiquitinating BRD4","volume":"71","author":"Jin","year":"2018","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0750","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molcel.2007.06.009","article-title":"Cdc20: a WD40 activator for a cell cycle degradation machine","volume":"27","author":"Yu","year":"2007","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb0755","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/sj.onc.1210799","article-title":"CDC20, a potential cancer therapeutic target, is negatively regulated by p53","volume":"27","author":"Kidokoro","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189560_bb0760","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2015.04.002","article-title":"Targeting Cdc20 as a novel cancer therapeutic strategy","volume":"151","author":"Wang","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0765","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/bjc.2014.252","article-title":"Cdc20 and securin overexpression predict short-term breast cancer survival","volume":"110","author":"Karra","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0770","first-page":"722","article-title":"Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis","volume":"7","author":"Ding","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0775","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s13277-015-3808-1","article-title":"A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage","volume":"37","author":"Gayyed","year":"2016","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb0780","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3892\/ijo.2016.3671","article-title":"Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel","volume":"49","author":"Li","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0785","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bbamcr.2009.11.001","article-title":"TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells","volume":"1793","author":"Kikuchi","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0790","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1083\/jcb.201609081","article-title":"Mechanistic insights into mammalian stress granule dynamics","volume":"215","author":"Panas","year":"2016","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb0795","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopha.2013.06.006","article-title":"Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells","volume":"67","author":"Gong","year":"2013","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0800","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3892\/ol.2020.11712","article-title":"Caprin-1 promotes HepG2 cell proliferation, invasion and migration and is associated with poor prognosis in patients with liver cancer","volume":"20","author":"Guo","year":"2020","journal-title":"Oncol. Lett."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb0805","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/dna.1996.15.855","article-title":"Molecular cloning of Elk-3, a new member of the Ets family expressed during mouse embryogenesis and analysis of its transcriptional repression activity","volume":"15","author":"Nozaki","year":"1996","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189560_bb0810","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2406159","article-title":"Silencing of ELK3 induces S-M phase arrest and apoptosis and upregulates SERPINE1 expression reducing migration in prostate cancer cells","volume":"2020","author":"Mao","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbcan.2026.189560_bb0815","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.ctdb.2016.10.002","article-title":"Homeodomain-interacting protein kinases: diverse and complex roles in development and disease","volume":"123","author":"Blaquiere","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0820","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/bies.201200060","article-title":"HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis","volume":"35","author":"Hofmann","year":"2013","journal-title":"Bioessays"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb0825","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41422-023-00874-4","article-title":"Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate","volume":"33","author":"Wu","year":"2023","journal-title":"Cell Res."},{"issue":"26","key":"10.1016\/j.bbcan.2026.189560_bb0830","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1038\/onc.2014.278","article-title":"Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1gamma","volume":"34","author":"Akaike","year":"2015","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0835","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201900127","article-title":"Cell fate regulation upon DNA damage: p53 serine 46 kinases pave the cell death road","volume":"41","author":"Liebl","year":"2019","journal-title":"Bioessays"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncb715","article-title":"Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2","volume":"4","author":"Hofmann","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0845","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ncb714","article-title":"Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis","volume":"4","author":"D\u2019Orazi","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncb3452","article-title":"The control of DNA repair by the cell cycle","volume":"19","author":"Hustedt","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0855","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/s41467-023-37499-5","article-title":"TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0860","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41594-024-01381-9","article-title":"Shieldin and CST co-orchestrate DNA polymerase-dependent tailed-end joining reactions independently of 53BP1-governed repair pathway choice","volume":"32","author":"King","year":"2025","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0865","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0092-8674(00)81209-X","article-title":"Geminin, an inhibitor of DNA replication, is degraded during mitosis","volume":"93","author":"McGarry","year":"1998","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189560_bb0870","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1101\/gad.379706","article-title":"Geminin is essential to prevent endoreduplication and to form pluripotent cells during mammalian development","volume":"20","author":"Gonzalez","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189560_bb0875","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2741\/2175","article-title":"Cdt1 and geminin: role during cell cycle progression and DNA damage in higher eukaryotes","volume":"12","author":"Tada","year":"2007","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0880","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1038\/s41467-021-26049-6","article-title":"SPOP mutation induces replication over-firing by impairing geminin ubiquitination and triggers replication catastrophe upon ATR inhibition","volume":"12","author":"Ma","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188415","article-title":"MCM family in gastrointestinal cancer and other malignancies: from functional characterization to clinical implication","volume":"1874","author":"Wang","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0890","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/MMBR.68.1.109-131.2004","article-title":"Eukaryotic MCM proteins: beyond replication initiation","volume":"68","author":"Forsburg","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb0895","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.7150\/jca.22691","article-title":"Expression of Minichromosome maintenance proteins (MCM) and Cancer prognosis: A meta-analysis","volume":"9","author":"Gou","year":"2018","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb0900","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1038\/s41467-023-38919-2","article-title":"macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma","volume":"14","author":"Nikolic","year":"2023","journal-title":"Nat. Commun."},{"issue":"6498","key":"10.1016\/j.bbcan.2026.189560_bb0905","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/371606a0","article-title":"Insulin-promoter-factor 1 is required for pancreas development in mice","volume":"371","author":"Jonsson","year":"1994","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0910","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00006676-200403000-00001","article-title":"PDX-1 and the pancreas","volume":"28","author":"Ashizawa","year":"2004","journal-title":"Pancreas"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb0915","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14728222.2017.1381087","article-title":"Fatty acid synthase (FASN) as a therapeutic target in breast cancer","volume":"21","author":"Menendez","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb0920","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0925","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.011338","article-title":"Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development","volume":"6","author":"Baenke","year":"2013","journal-title":"Dis. Model. Mech."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb0930","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0935","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.celrep.2017.12.081","article-title":"Loss of an androgen-inactivating and isoform-specific HSD17B4 splice form enables emergence of castration-resistant prostate Cancer","volume":"22","author":"Ko","year":"2018","journal-title":"Cell Rep."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189560_bb0940","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jsbmb.2007.02.009","article-title":"Regulation of 17beta-hydroxysteroid dehydrogenase type 2, type 4 and type 5 by calcitriol, LXR agonist and 5alpha-dihydrotestosterone in human prostate cancer cells","volume":"107","author":"Wang","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0945","first-page":"854","article-title":"CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors","volume":"6","author":"Chen","year":"2025","journal-title":"Nat. Can."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb0950","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tibs.2007.05.002","article-title":"Modification in reverse: the SUMO proteases","volume":"32","author":"Mukhopadhyay","year":"2007","journal-title":"Trends Biochem. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb0955","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1474-9726.2008.00411.x","article-title":"Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts","volume":"7","author":"Yates","year":"2008","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0960","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/BJ20070940","article-title":"Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family","volume":"409","author":"Drag","year":"2008","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb0965","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1128\/MCB.01830-05","article-title":"Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2","volume":"26","author":"Itahana","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189560_bb0970","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1074\/jbc.M511658200","article-title":"Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3","volume":"281","author":"Gong","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/j.bbcan.2026.189560_bb0975","doi-asserted-by":"crossref","first-page":"17466","DOI":"10.1073\/pnas.1209378109","article-title":"Differential expression of SUMO-specific protease 7 variants regulates epithelial-mesenchymal transition","volume":"109","author":"Bawa-Khalfe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7528","key":"10.1016\/j.bbcan.2026.189560_bb0980","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189560_bb0985","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb0990","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40618-019-01112-8","article-title":"Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study","volume":"43","author":"Presotto","year":"2020","journal-title":"J. Endocrinol. Investig."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb0995","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.seminoncol.2017.06.007","article-title":"Nivolumab and pembrolizumab: monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable","volume":"44","author":"Prasad","year":"2017","journal-title":"Semin. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb1000","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1200\/JCO.22.02270","article-title":"Phase I study of single-agent anti-programmed Death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"41","author":"Brahmer","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.bbcan.2026.189560_bb1005","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"49","key":"10.1016\/j.bbcan.2026.189560_bb1010","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1038\/onc.2009.286","article-title":"Genetic inactivation of ApoJ\/clusterin: effects on prostate tumourigenesis and metastatic spread","volume":"28","author":"Bettuzzi","year":"2009","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb1015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/thno.29271","article-title":"RACK1 promotes self-renewal and Chemoresistance of Cancer stem cells in human hepatocellular carcinoma through stabilizing Nanog","volume":"9","author":"Cao","year":"2019","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb1020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","article-title":"Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease","volume":"131","author":"Yang","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb1025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189560_bb1030","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1016\/j.cell.2021.08.035","article-title":"Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion","volume":"184","author":"Nader","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb1035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2032-5\u2019 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb1040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10875-015-0147-3","article-title":"Human disease phenotypes associated with mutations in TREX1","volume":"35","author":"Rice","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb1045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-23-0700","article-title":"TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes antitumor immunity","volume":"14","author":"Tani","year":"2024","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189560_bb1055","article-title":"Targeting phagocytosis checkpoints for cancer immunotherapy","author":"Veillette","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1060","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1038\/s41467-025-59621-5","article-title":"USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity","volume":"16","author":"Dai","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb1065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033208","article-title":"Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3\/CHOP\/GADD153","volume":"7","author":"Jauhiainen","year":"2012","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189560_bb1070","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood.2019004292","article-title":"Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia","volume":"136","author":"Matsumura","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb1075","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.7150\/jca.96491","article-title":"DDIT3 is associated with breast cancer prognosis and immune microenvironment: an integrative bioinformatic and immunohistochemical analysis","volume":"15","author":"Yu","year":"2024","journal-title":"J. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb1080","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1158\/1541-7786.MCR-23-0648","article-title":"MLLT6\/ATF2 Axis restrains breast Cancer progression by driving DDIT3\/4 expression","volume":"22","author":"Yu","year":"2024","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb1085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052836","article-title":"Integrated bioinformatics analysis identified ASNS and DDIT3 as the therapeutic target in castrate-resistant prostate cancer","volume":"25","author":"Jung","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"36","key":"10.1016\/j.bbcan.2026.189560_bb1090","doi-asserted-by":"crossref","first-page":"26754","DOI":"10.1074\/jbc.M604666200","article-title":"INF2 is a WASP homology 2 motif-containing formin that severs actin filaments and accelerates both polymerization and depolymerization","volume":"281","author":"Chhabra","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb1095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006748","article-title":"Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer","volume":"13","author":"Jin","year":"2017","journal-title":"PLoS Genet."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb1100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1101\/gad.1284005","article-title":"Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9","volume":"19","author":"Tachibana","year":"2005","journal-title":"Genes Dev."},{"issue":"27","key":"10.1016\/j.bbcan.2026.189560_bb1105","doi-asserted-by":"crossref","first-page":"25309","DOI":"10.1074\/jbc.M101914200","article-title":"Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3","volume":"276","author":"Tachibana","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb1110","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb1115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cvr\/cvae023","article-title":"Sequestosome 1 (p62) mitigates hypoxia-induced cardiac dysfunction by stabilizing hypoxia-inducible factor 1alpha and nuclear factor erythroid 2-related factor 2","volume":"120","author":"Ghosh","year":"2024","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb1120","first-page":"3210","article-title":"Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells","volume":"5","author":"Gao","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"47","key":"10.1016\/j.bbcan.2026.189560_bb1125","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1038\/s41388-018-0396-8","article-title":"LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer","volume":"37","author":"Luo","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb1130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbrc.2011.10.154","article-title":"Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex","volume":"415","author":"Kim","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1135","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1038\/s41467-022-30559-2","article-title":"Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3(SPOP) E3 ligase in cancer cells","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41420-022-01182-3","article-title":"The speckle-type POZ protein (SPOP) inhibits breast cancer malignancy by destabilizing TWIST1","volume":"8","author":"Wei","year":"2022","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb1145","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.47","article-title":"Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-alpha protein turnover","volume":"6","author":"Zhang","year":"2015","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13578-022-00950-z","article-title":"SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF","volume":"12","author":"Feng","year":"2022","journal-title":"Cell Biosci."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189560_bb1155","first-page":"2797","article-title":"SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer","volume":"9","author":"Jin","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb1160","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41418-022-01097-7","article-title":"SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis","volume":"30","author":"Gao","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189560_bb1165","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89951","article-title":"SPOP targets the immune transcription factor IRF1 for proteasomal degradation","volume":"12","author":"Schwartz","year":"2023","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb1170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41419-022-04619-w","article-title":"Degradation of DRAK1 by CUL3\/SPOP E3 ubiquitin ligase promotes tumor growth of paclitaxel-resistant cervical cancer cells","volume":"13","author":"Pang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12967-022-03574-6","article-title":"SPOP promotes cervical cancer progression by inducing the movement of PD-1 away from PD-L1 in spatial localization","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb1180","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005270","article-title":"CUL3\/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein","volume":"10","author":"Dong","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2018.05.115","article-title":"Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1\/sentrin specific peptidase 7","volume":"502","author":"Ji","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189560_bb1190","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41388-022-02589-z","article-title":"O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma","volume":"42","author":"Zhou","year":"2023","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189560_bb1195","article-title":"CSN6-SPOP-HMGCS1 Axis promotes hepatocellular carcinoma progression via YAP1 activation","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00018-024-05144-z","article-title":"BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma","volume":"81","author":"Yu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2026.189560_bb1205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.omto.2020.09.008","article-title":"S119N mutation of the E3 ubiquitin ligase SPOP suppresses SLC7A1 degradation to regulate Hepatoblastoma progression","volume":"19","author":"He","year":"2020","journal-title":"Mol. Ther. Oncol."},{"issue":"29","key":"10.1016\/j.bbcan.2026.189560_bb1210","doi-asserted-by":"crossref","first-page":"47890","DOI":"10.18632\/oncotarget.18141","article-title":"Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6","volume":"8","author":"Tan","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb1215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41422-019-0257-1","article-title":"ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer","volume":"30","author":"Li","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13046-014-0075-8","article-title":"SPOP suppresses tumorigenesis by regulating Hedgehog\/Gli2 signaling pathway in gastric cancer","volume":"33","author":"Zeng","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167032","article-title":"Deficiency in SPOP-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression","volume":"1870","author":"Liu","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb1230","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41419-019-2017-z","article-title":"SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG","volume":"10","author":"Tan","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbrc.2018.08.176","article-title":"SPOP promotes FADD degradation and inhibits NF-kappaB activity in non-small cell lung cancer","volume":"504","author":"Luo","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189560_bb1240","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbrc.2017.01.027","article-title":"SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth","volume":"483","author":"Luo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189560_bb1245","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41375-019-0661-z","article-title":"CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88\/NF-kappaB signaling","volume":"34","author":"Jin","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1250","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12967-022-03476-7","article-title":"Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphoma","volume":"20","author":"Yan","year":"2022","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb1255","first-page":"2428","article-title":"SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation","volume":"10","author":"Yuan","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189560_bb1260","article-title":"SPOP and OTUD7A control EWS-FLI1 protein stability to govern Ewing sarcoma growth","volume":"8","author":"Su","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189560_bb1265","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.7150\/thno.101575","article-title":"SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3\/CCL2\/IL-6 axis and is regulated by VEZF1","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189560_bb1270","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1158\/0008-5472.CAN-17-3386","article-title":"Therapeutic targeting of Sunitinib-induced AR phosphorylation in renal cell carcinoma","volume":"78","author":"Adelaiye-Ogala","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1275","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/nar\/gkw814","article-title":"SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing","volume":"45","author":"Zhu","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189560_bb1280","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ccell.2016.08.003","article-title":"Small-molecule targeting of E3 ligase adaptor SPOP in kidney Cancer","volume":"30","author":"Guo","year":"2016","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb1285","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1021\/acs.jmedchem.0c00161","article-title":"Structure-activity relationship of SPOP inhibitors against kidney cancer","volume":"63","author":"Dong","year":"2020","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb1290","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.str.2012.04.009","article-title":"Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase","volume":"20","author":"Errington","year":"2012","journal-title":"Structure"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb1295","doi-asserted-by":"crossref","first-page":"8634","DOI":"10.1021\/acs.jmedchem.5c00295","article-title":"Harnessing the SPOP E3 ubiquitin ligase via a bridged proteolysis targeting chimera (PROTAC) strategy for targeted protein degradation","volume":"68","author":"Deng","year":"2025","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189560_bb1300","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189560_bb1305","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1535-7163.MCT-18-1129","article-title":"Acquired resistance to BET-PROTACs (proteolysis-targeting chimeras) caused by genomic alterations in Core components of E3 ligase complexes","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189560_bb1310","doi-asserted-by":"crossref","first-page":"11218","DOI":"10.1021\/acs.jmedchem.9b01393","article-title":"Discovery of highly potent and efficient PROTAC degraders of androgen receptor (AR) by employing weak binding affinity VHL E3 ligase ligands","volume":"62","author":"Han","year":"2019","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189560_bb1315","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1158\/1078-0432.CCR-23-1439","article-title":"SPOP mutations target STING1 signaling in prostate Cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression","volume":"29","author":"Geng","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189560_bb1320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197293","article-title":"The roles of SPOP in DNA damage response and DNA replication","volume":"21","author":"Maekawa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189560_bb1325","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.186871","article-title":"SPOP mutations increase PARP inhibitor sensitivity via CK2\/PIAS1\/SPOP axis in prostate cancer","volume":"10","author":"Zhang","year":"2025","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb1330","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2023.11.014","article-title":"Co-occurring BRCA2\/SPOP mutations predict exceptional poly (adp-ribose) polymerase inhibitor sensitivity in metastatic castration-resistant prostate cancer","volume":"7","author":"Orme","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb1335","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040892","article-title":"Precision targets for intercepting the lethal progression of prostate cancer: potential avenues for personalized therapy","volume":"14","author":"Christenson","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189560_bb1340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6230","key":"10.1016\/j.bbcan.2026.189560_bb1345","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Chan, Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189560_bb1350","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.euo.2024.04.011","article-title":"Prognostic and predictive role of SPOP mutations in prostate Cancer: A systematic review and Meta-analysis","volume":"7","author":"Pedrani","year":"2024","journal-title":"Eur Urol. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189560_bb1355","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.celrep.2014.01.013","article-title":"Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants","volume":"6","author":"An","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189560_bb1360","doi-asserted-by":"crossref","unstructured":"Erratum for the Research Article \"ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication\" by D. Wang et al, Sci Adv 11(26) (2025) eadz5386.","DOI":"10.1126\/sciadv.adz5386"},{"key":"10.1016\/j.bbcan.2026.189560_bb1365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2020.10.019","article-title":"TinghuaiWang, the GPER1\/SPOP axis mediates ubiquitination-dependent degradation of ERalpha to inhibit the growth of breast cancer induced by oestrogen","volume":"498","author":"Zhang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189560_bb1370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102795","article-title":"SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression","volume":"56","author":"Wang","year":"2020","journal-title":"EBioMedicine"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:43:59Z","timestamp":1782031439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":274,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0304419X26000326"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189560","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular insights for the tumor suppressor role of SPOP in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189560"}}